all press releases

  • 12/15/16
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today applauds passage of the revised 21st Century Cures Act, which was signed into law by President Obama on Tuesday, December 13. The law is designed to spur biomedical innovations, improve processes and provide new funding for the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). The investments included in the law have the potential to markedly enhance health care delivery, andmore...
  • 12/05/16
    IRVING, Texas--(BUSINESS WIRE)--As businesses around the world, including those in the healthcare industry, are beginning to recognize the negative impact that chemicals have on human health and the environment, Vizient, Inc. today announced a major step toward measuring and voluntarily phasing out toxic chemicals. In partnership with the Chemical Footprint Project, the first-ever common metric for publicly benchmarking chemical use and management, Vizient ismore...
  • 12/01/16
    IRVING, Texas--(BUSINESS WIRE)--In letters to members of the House and Senate, Vizient, Inc. announced its support for passage of the revised 21st Century Cures Act, noting that the legislation represents meaningful bipartisan work aimed at improving patient care by investing in systems that are catalysts for biomedical innovations. Vizient is the nation’s largest health care performance improvement company serving a diverse membership that includes academic medical centers,more...
  • 11/29/16
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announced today that it will participate in three educational sessions at the ASHP 2016 Midyear Clinical Meeting and Exhibition, December 4-8 in Las Vegas, Nevada. With its focus on improving patient care and medication safety, the ASHP event is expected to be attended by more than 20,000 pharmacy professionals from around the globe. Vizient’s Steven Lucio, Pharm.D., BCPS, Associate Vice President Clinicalmore...
  • 11/21/16
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announced it won two silver and one bronze award for its brand development and rebranding efforts from Transform magazine. The magazine’s annual awards honor the most innovative, creative and successful brand work across the world. Each of the prestigious award programs focus on specific aspects of the branding process and provides a platform from which to benchmark and showcase excellence. The awards received bymore...
  • 11/03/16
    IRVING, Texas--(BUSINESS WIRE)--Each year in the United States, at least two million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections. As part of its support of The Centers for Disease Control and Prevention’s (CDC) Get Smart About Antibiotics Week 2016, Vizient Inc. is hosting two free educational webinars for health care professionals to help raise awareness of the threat ofmore...
  • 11/02/16
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced it will be presenting on the “Successful Commercialization of Biosimilars” to the hospital market segment at the Third Annual Biosimilars North America conference, November 17-18 in Iselin, New Jersey. Vizient’s L. Ross Day, R.Ph. D.P., director of pharmacy, Sourcing Operations will make the presentation. The biosimilars market presents significant opportunities for pharmaceuticals and biotechmore...
  • 10/24/16
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced that Dr. David Levine has been promoted to senior vice president, Advanced Analytics and Informatics. “I am pleased to announce David’s promotion. He has been responsible for driving a number of key initiatives for Vizient, including growing our Center for Advanced Analytics, leading the development of our risk adjustment methodologies and increasing the engagement of physicians and other cliniciansmore...
  • 10/04/16
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced the product categories and suppliers participating in its Quarter 4 National Group Buy Program available October 1 through December 31, 2016. The National Group Buy Program is one of several innovative programs from Vizient designed to deliver additional savings each quarter to the hospitals it serves. GE Healthcare, the Quarter 4 featured supplier, is offering significant savings on theirmore...
  • 10/03/16
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced 3Derm as the winner of its Innovation Challenge, an interactive competition between five health care start-up companies. The competition was held Friday, September 30 during the Vizient 2016 Clinical Connections Summit at the Hyatt Regency Dallas. The annual member event drew more than 2,200 attendees which included representatives from 350 member hospitals and health systems. The Vizientmore...

Connect with us